Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
6
×
boston blog main
6
×
boston top stories
life sciences
national blog main
san diego blog main
san diego top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
national
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
gene therapy
novartis
praluent
alzheimer's
amgen
biogen
boston
donald trump
fda
merck
pbm
regeneron pharmaceuticals
rejection
What
healthcare
6
×
bio
roundup
drug
industry
life
moves
public
america
american
based
becker
best
billions
biogen
biotech
boston
censinet
cholesterol
continue
continues
convoluted
crash
cyber
debate
democrats
dollars
dreams
driving
drugs
eaton
expensive
faces
financial
foe
gene
good
head
headaches
helping
Language
unset
Current search:
healthcare
×
biotech
×
" boston blog main "
×
@xconomy.com
4 years ago
Drug Pricing: Innovation, Investment, and the Public Good
@xconomy.com
4 years ago
New PCSK9 Cholesterol Drug Faces Tough Foe. (Hint: Not Cholesterol.)
@xconomy.com
4 years ago
Bio Roundup: Michael Becker, Suzanne Eaton, Gene Therapy Moves & More
@xconomy.com
5 years ago
Bio Roundup: Head and Spine Previews, Biogen Moves, IPO Dreams & More
@xconomy.com
5 years ago
Censinet Takes Off With $7.8M to Track Cyber Risks in Healthcare
@xconomy.com
5 years ago
Bio Roundup: Trump’s Scalps, Policy Pressure, NASH Crash & More